Sugentech Inc
Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers lab tests, including systems and test items; and COVID-19 tests. It also provides point of care testing analyzers and test items for testing of influenza A/B, antibody test, COVID-19 and flu, SARS-CoV-2… Read more
Sugentech Inc (253840) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.047x
Based on the latest financial reports, Sugentech Inc (253840) has a cash flow conversion efficiency ratio of -0.047x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-4.13 Billion) by net assets (₩87.93 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sugentech Inc - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Sugentech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Sugentech Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sugentech Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Yulon Nissan Motor Co Ltd
TW:2227
|
-0.007x |
|
Holiday Entertainment Co Ltd
TW:9943
|
0.098x |
|
Guerbet SA
F:4G8
|
-0.042x |
|
Ratchaphruek Hospital Public Company Limited
BK:RPH
|
0.046x |
|
Lingotes
MC:LGT
|
-0.062x |
|
RediShred Capital Corp
PINK:RDCPF
|
0.052x |
|
NACL Industries Limited
NSE:NACLIND
|
-0.201x |
|
Airgain Inc
NASDAQ:AIRG
|
-0.014x |
Annual Cash Flow Conversion Efficiency for Sugentech Inc (2017–2024)
The table below shows the annual cash flow conversion efficiency of Sugentech Inc from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩97.13 Billion | ₩-7.52 Billion | -0.077x | +28.39% |
| 2023-12-31 | ₩112.45 Billion | ₩-12.15 Billion | -0.108x | -149.93% |
| 2022-12-31 | ₩140.58 Billion | ₩30.43 Billion | 0.216x | -44.04% |
| 2021-12-31 | ₩100.71 Billion | ₩38.96 Billion | 0.387x | +67.51% |
| 2020-12-31 | ₩63.11 Billion | ₩14.57 Billion | 0.231x | +239.92% |
| 2019-12-31 | ₩24.31 Billion | ₩-4.01 Billion | -0.165x | +18.61% |
| 2018-12-31 | ₩15.46 Billion | ₩-3.13 Billion | -0.203x | -831.42% |
| 2017-12-31 | ₩-32.81 Billion | ₩-909.59 Million | 0.028x | -- |